Clinical Trials Browser

Phase 2 × Lung Neoplasms × envafolimab × Clear all

NCT05203276 2023-06-22

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

Phase 2 Unknown

Lung Neoplasms